期刊
THORACIC SURGERY CLINICS
卷 30, 期 2, 页码 221-239出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.thorsurg.2020.01.002
关键词
Immunotherapy; Immune checkpoint inhibitors; Radiation therapy; Lung cancer; Systemic therapy
Immune checkpoint inhibitors have recently been demonstrated to improve survival in metastatic and locally advanced non-small cell lung cancer (NSCLC). Radiation therapy has a well-established role in the treatment of NSCLC and has more recently been shown to be immunostimulatory, with the potential to enhance the efficacy of immunotherapy. This comprehensive review details the current roles of radiation therapy and immune checkpoint inhibitors in NSCLC, discusses the intersection of these two modalities and their potential to have combined synergistic responses, and highlights existing preclinical and clinical data and ongoing clinical trials of combined immunotherapy and radiotherapy across all NSCLC stages.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据